Jones Financial Companies
INO icon

Jones Financial Companies’s Inovio Pharmaceuticals INO Stock Holding History

Jones Financial Companies’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264 Hold
240
– – ﹤0.01% 4831
2026
Q1 		$386 Hold
240
– – ﹤0.01% 4532
2025
Q4 		$418 Sell
240
-6
-2% -$13 ﹤0.01% 4190
2025
Q3 		$610 Hold
246
– – ﹤0.01% 3997
2025
Q2 		$519 Buy
246
+228
+1,267% +$437 ﹤0.01% 3800
2025
Q1 		$31 Sell
18
-183
-91% -$367 ﹤0.01% 3671
2024
Q4 		$368 Sell
201
-31
-13% -$137 ﹤0.01% 3263
2024
Q3 		$1.36K Buy
232
+25
+12% +$206 ﹤0.01% 2753
2024
Q2 		$1.67K Buy
+207
New +$2.18K ﹤0.01% 2199

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jones Financial Companies's INO Position: Q2 2026 in Review

Jones Financial Companies held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 240 shares worth $264. The position accounts for ﹤0.01% of the portfolio, ranked #4831.

Jones Financial Companies first reported a position in INO in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.67K in Q2 2024. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Jones Financial Companies held 240 shares of Inovio Pharmaceuticals worth $264 as of Q2 2026.
  • Jones Financial Companies left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4831 holding.
  • Jones Financial Companies first reported a position in Inovio Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Jones Financial Companies's Inovio Pharmaceuticals position peaked at $1.67K in Q2 2024.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.